Level Four Advisory Services’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

Level Four Advisory Services’s Portfolio GTHX Stock Details GTHX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-178,600	Closed	-$545K	–	918
2024 Q1	$545K	Hold	178,600	–	–	0.03%	446
2023 Q4	$545K	Sell	178,600 -4,800	-3%	-$9.02K	0.03%	444
2023 Q3	$264K	Buy	183,400 +95,500	+109%	+$185K	0.02%	604
2023 Q2	$219K	Buy	87,900 +1,400	+2%	+$3.83K	0.01%	712
2023 Q1	$232K	Buy	+86,500	New	+$416K	0.02%	649

Other funds holding GTHX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Level Four Advisory Services's GTHX Position: Q2 2024 in Review

Level Four Advisory Services sold out of G1 Therapeutics, Inc. Common Stock (GTHX) in Q2 2024, closing a stake of 178,600 shares — an estimated $545K sold.

Level Four Advisory Services first reported a position in GTHX in Q1 2023 and held it in 5 quarters. The position peaked at $545K in Q1 2024. 88 funds tracked by Wall St. Rank hold GTHX as of Q2 2024.

Level Four Advisory Services reported no remaining G1 Therapeutics, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Level Four Advisory Services sold 178,600 G1 Therapeutics, Inc. Common Stock shares in Q2 2024, an estimated $545K.
Level Four Advisory Services first reported a position in G1 Therapeutics, Inc. Common Stock in Q1 2023 and held it in 5 quarters.
Level Four Advisory Services's G1 Therapeutics, Inc. Common Stock position peaked at $545K in Q1 2024.
88 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q2 2024.

Based on Level Four Advisory Services's 13F filing for Q2 2024, filed 9 Aug 2024.